All antibody forms (polyclonal, hybridoma-based monoclonal and recombinant monoclonal) have advantages and disadvantages for development, validation and use. It depends on your project. Polyclonal antibodies are ideal reagents in assay-specific target discovery and detection. They display multi-epitope binding properties which make these reagents ideally suited for many applications. The clonal and biophysical diversity of polyclonal antibodies allows for greater sensitivity and utility in certain types of applications. And CUSABIO’s polyclonal antibodies should be on your reagents list.
CUSABIO polyclonal antibodies are all prepared with recombinant protein or native protein. Compared with peptide antibodies, affinity and specificity is superior. Moreover, there're more recognition of antigenic sites and have a much wider range of applications. Antibodies purified by affinity chromatography possess high purity.
As to quality control, CUSABIO proves the antibodies sensitivity and discriminating on natural proteins by rigorous ELISA test, and verify their specificity by Western blot test. It turns out that CUSABIO polyclonal antibodies have a broader scope of application and they a powerful tool for scientific research.
You will find more details on the images of validated applications.
CFHR5 Antibody (CSB-PA883624LA01HU)
STYX Antibody (CSB-PA851966LA01HU)
2-hydroxyisobutyryl-HIST1H1C (K109) Antibody (CSB-PA010378OA109hibHU)
2-hydroxyisobutyryl-HIST1H3A (K18) Antibody (CSB-PA010418PA18hibHU)
LGALS4 Antibody (CSB-PA012889LA01HU)
WDR73 Antibody (CSB-PA744047LA01HU)
TNFRSF1A Antibody (CSB-PA023977LA01HU)
UMODL1 Antibody (CSB-PA025617LA01HU)
Here is the catalog of all polyclonal antibodies. You can find the right ones for your research, or search them in the search box on the header part of this website.
If you can’t find the antibody you need in the catalog, please check CUSABIO Polyclonal Antibody Custom Service.
Product Name |
Code |
Species Reactivity |
Application |
Size |
---|---|---|---|---|
ABCA3 Antibody |
CSB-PA827811 | Human | ELISA, WB, IF | 100μl/50μl |
TRAF7 Antibody |
CSB-PA780056 | Human, Mouse | ELISA, WB | 100μg/50μg |
SLC17A8 Antibody |
CSB-PA107772 | Human | ELISA, WB | 100μl/50μl |
ALX4 Antibody |
CSB-PA246721 | Human, Mouse | ELISA, WB | 100μl/50μl |
CHRNA7 Antibody |
CSB-PA188517 | Human, Mouse, Rat | ELISA, WB | 100μg/50μg |
CTAG2 Antibody |
CSB-PA029753 | Human, Mouse, Rat | ELISA, WB | 100μg/50μg |
SLC10A2 Antibody |
CSB-PA843819 | Human, Mouse | ELISA, WB | 100μg/50μg |
PNPLA3 Antibody |
CSB-PA154215 | Human, Mouse | WB, ELISA | 100μg/50μg |
A29L Antibody |
CSB-PA46839LA01MPX | Monkeypox virus (strain Zaire-96-I-16) | ELISA, WB | 100μl/50μl |
DEFA6 Antibody |
CSB-PA980801GA01HU | Human | ELISA, WB, IHC | 100μl |
RPL28 Antibody, Biotin conjugated |
CSB-PA020217ED01HU | Human | ELISA, IHC | 100μg/50μg |
dcyD Antibody, Biotin conjugated |
CSB-PA18017D0Rb | Escherichia coli | ELISA, WB | 100μg/50μg |
HLA-DRB1 Antibody, Biotin conjugated |
CSB-PA17949D0Rb | Human | ELISA, IHC | 100μg/50μg |
HLA-C Antibody, Biotin conjugated |
CSB-PA15099D0Rb | Human | ELISA, IHC | 100μg/50μg |
HLA-B Antibody, Biotin conjugated |
CSB-PA15089D0Rb | Human | ELISA, IHC | 100μg/50μg |
APX2 Antibody, HRP conjugated |
CSB-PA14419B0Rb | Arabidopsis thaliana | ELISA, WB | 100μg/50μg |
YWHAH Antibody, Biotin conjugated |
CSB-PA02174D0Rb | Human | ELISA, IHC | 100μg/50μg |
AP1S3 Antibody, Biotin conjugated |
CSB-PA001868ED01HU | Human | ELISA, IHC | 100μg/50μg |
Anxa1 Antibody, HRP conjugated |
CSB-PA001836YB01MO | Mouse, Human | ELISA, WB | 100μg/50μg |
TMPRSS2 Antibody |
CSB-PA971239 | Human | ELISA, WB | 100μl/50μl |
S100A8 Antibody |
CSB-PA020641GA01HU | Human,Mouse,Rat | ELISA,WB,IHC | 100μl |
CYR61 Antibody |
CSB-PA940403 | Human,Mouse,Rat | WB, ELISA | 100μg/50μg |
S Antibody, Biotin conjugated |
CSB-PA33245YD11GMY | Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) | ELISA | 100μl/50μl |
S Antibody, FITC conjugated |
CSB-PA33245YC11GMY | Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) | 100μl/50μl | |
S Antibody, HRP conjugated |
CSB-PA33245YB11GMY | Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) | ELISA | 100μl/50μl |
S Antibody |
CSB-PA33245YA11GMY | Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) | ELISA | 100μl/50μl |
S Antibody, Biotin conjugated |
CSB-PA33245YD01GMY | Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) | ELISA | 100μl/50μl |
S Antibody |
CSB-PA33245YA01GMY | Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) | ELISA | 100μl/50μl |
SPARCL1 Antibody |
CSB-PA945237 | Human, Mouse, Rat | WB, ELISA: WB:1:500-2000, ELISA:1:5000-20000 | 100μg/50μg |
ABHD10 Antibody |
CSB-PA591994 | Human, Rat | WB ,ELISA | 100μg/50μg |
N Antibody, HRP conjugated |
CSB-PA33254B0Rb | Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) | ELISA, WB | 100ul/50ul |
N Antibody |
CSB-PA33254A0Rb | Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) | WB, ELISA | 100ul/50ul |
HLA-G Antibody, Biotin conjugated |
CSB-PA010509LD01HU | Human | ELISA | 100μl/50μl |
GCG Antibody, Biotin conjugated |
CSB-PA009315LD11HU | Human | ELISA | 100μl/50μl |
FST Antibody, HRP conjugated |
CSB-PA009024LB01HU | Human | ELISA | 100μl/50μl |
CLDN11 Antibody, FITC conjugated |
CSB-PA005492LC11HU | Human | 100μl/50μl | |
CA9 Antibody, Biotin conjugated |
CSB-PA614990LD01HU | Human | ELISA | 100μl/50μl |
Apoa1 Antibody, Biotin conjugated |
CSB-PA001913LD01RA | Rat | ELISA | 100μl/50μl |
YAP1 Antibody, Biotin conjugated |
CSB-PA026244LD11HU | Human | ELISA | 100μl/50μl |
YAP1 Antibody, FITC conjugated |
CSB-PA026244LC11HU | Human | 100μl/50μl | |
YAP1 Antibody, HRP conjugated |
CSB-PA026244LB11HU | Human | ELISA | 100μl/50μl |
YAP1 Antibody |
CSB-PA026244LA11HU | Human | ELISA, WB, IF | 100μl/50μl |
YAP1 Antibody, Biotin conjugated |
CSB-PA026244LD01HU | Human | ELISA | 100μl/50μl |
YAP1 Antibody, FITC conjugated |
CSB-PA026244LC01HU | Human | 100μl/50μl | |
YAP1 Antibody, HRP conjugated |
CSB-PA026244LB01HU | Human | ELISA | 100μl/50μl |
YAP1 Antibody |
CSB-PA026244LA01HU | Human | ELISA, IHC, IF | 100μl/50μl |
VPS26A Antibody, Biotin conjugated |
CSB-PA025898LD11HU | Human | ELISA | 100μl/50μl |
VPS26A Antibody, FITC conjugated |
CSB-PA025898LC11HU | Human | 100μl/50μl | |
VPS26A Antibody, HRP conjugated |
CSB-PA025898LB11HU | Human | ELISA | 100μl/50μl |
VPS26A Antibody |
CSB-PA025898LA11HU | Human | ELISA, IHC | 100μl/50μl |
What are polyclonal antibodies?
As known to all, Polyclonal Antibodies represent a heterogeneous mix of antibodies from different B cells that recognize multiple epitopes on the same antigen. Each of these individual antibodies recognizes a unique epitope that is located on that antigen.
Polyclonal antibodies vs Monoclonal antibodies
Since polyclonal antibodies are mentioned, monoclonal antibodies are usually never left out. Both polyclonal and monoclonal antibodies have their own features.
Compared with Monoclonal antibodies, the advantages and disadvantages of polyclonal antibody have been presented as follows:
Advantages:
Disadvantages:
SLC25A47 is a novel determinant of hepatic mitochondrial function implicated in liver fibrosis. Journal of Hepatology, 2022. (IF=25.083)
CUSABIO Antibody: YME1L1 Antibody, CSB-PA026267GA01HU
An Image-Based High-Throughput and High-Content Drug Screening Method Based on Microarray and Expansion Microscopy. ACS nano, 2023. (IF=18.027)
CUSABIO Antibody: TOMM20 Antibody, CSB-PA618983ESR2HU
Extracellular vesicles derived from Akkermansia muciniphila promote placentation and mitigate preeclampsia in a mouse model. Journal of extracellular vesicles, 2023. (IF=17.337)
CUSABIO Antibody: ompA Antibody, CSB-PA706579LA01RMS
AC-motif: a DNA motif containing adenine and cytosine repeat plays a role in gene regulation. Nucleic acids research, 2021. (IF=16.973)
CUSABIO Antibody: CDKL3 Antibody, CSB-PA150181; GAPDH Antibody, CSB-PA00025A0Rb
Mitochondria supply sub-lethal signals for cytokine secretion and DNA-damage in H. pylori infection. cell death & differentiation, 2022. (IF=15.828)
CUSABIO Antibody: TIFA Antibody, CSB-PA839301LA01HU